Investigating Secondary Alcohol Outcomes in a Contingency Management Intervention among American Indian and Alaska Native Adults : Journal of Addiction Medicine

Journal Logo

Original Research

Investigating Secondary Alcohol Outcomes in a Contingency Management Intervention among American Indian and Alaska Native Adults

Hirchak, Katherine A. PhD; Kordas, Gordon MS; Lyons, Abram J. MSW; Herron, Jalene MS; Jansen, Kelley MS; Shaw, Jennifer PhD; McPherson, Sterling M. PhD; Roll, John PhD; Buchwald, Dedra MD; McDonell, Michael G. PhD;  the HONOR Study Team

Author Information
Journal of Addiction Medicine 17(3):p e177-e182, 5/6 2023. | DOI: 10.1097/ADM.0000000000001116

Abstract

Objective 

The aim of the study is to investigate clinically meaningful, secondary outcomes in a randomized trial of a culturally adapted contingency management (CM) intervention for alcohol use in 3 diverse American Indian and Alaska Native communities.

Methods 

Three American Indian and Alaska Native communities located in the Northern Plains, Alaska, and the Inland Northwest were partnering sites. A total of 158 individuals were randomized to either a 12-week CM intervention or a noncontingent (NC) control group. The CM group received reinforcers for providing alcohol-negative ethyl glucuronide (EtG < 150 ng/mL) urine samples, while the NC group received reinforcers unconditionally. Outcomes included EtG as a continuous measure (range, 0–2,000 ng/mL), EtG > 499 ng/mL (a measure of higher levels of recent alcohol use), longest duration of abstinence, and time-to-first alcohol-positive EtG during the trial. Generalized estimating equations along with Cox proportional hazard and negative binomial regressions were used.

Results 

Participants randomized to the CM group had lower mean EtG levels (−241.9 ng/mL; 95% confidence interval [CI], −379.0 to −104.8 ng/mL) and 45.7% lower odds (95% CI, 0.31 to 0.95) of providing an EtG sample indicating higher levels of alcohol use during the intervention. Longest duration of abstinence was 43% longer for the CM group than the NC group (95% CI, 1.0 to 1.9). Risk of time-to-first drink during treatment did not differ significantly.

Conclusions 

These secondary outcome analyses provide evidence that CM is associated with reductions in alcohol use and longer durations of abstinence (as assessed by EtG), both clinically meaningful endpoints and analyses that differ from the primary study outcome.

Copyright © 2022 American Society of Addiction Medicine

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid